Michael Schilling is an experienced finance professional currently serving as a Finance Manager at NeoGenomics Laboratories since July 2018, where responsibilities include providing strategic financial analysis, leading monthly forecasts, and collaborating with business leaders to optimize financial performance in the Pharma Division. Prior to this role, Michael worked as a Senior Financial Analyst at NeoGenomics, focusing on budgeting and forecasting for the Clinical Division, and also held financial analyst positions at National Instruments and HID Global, where budgeting, variance analysis, and operational metrics were key responsibilities. Michael holds a Bachelor of Arts in Business Administration with a concentration in Finance from California State University, Fullerton.
This person is not in any teams
This person is not in any offices